London (PRWEB UK) 30 October 2013
"What are the drivers for adopting continuous processing?
•Cost, time and material savings throughout the product life-cycle associated with more consistent product quality
•The development of in-line measurements and process control mechanisms to correct any changes are critical for success
•Potential for real-time quality assurance (parametric release) and reduced analytical costs" – Continuous processing in the pharmaceutical industry changing the mindset ,Plumb K. (2005). Chem. Eng. Res. Design 83(A6), 730-738
On this topic SMi is proud to announce Mr. Marcel de Matas, Principal Scientist Formulation Science, AstraZeneca will be presenting at the 2nd annual Quality by Design conference about Shifting tides in pharmaceutical manufacturing — Making continuous processing a reality
Why attend this event:
Plus an interactive half-day post-conference workshop: Successfully Implementing Quality by Design: An introductory Workshop QbD & PAT, hosted by Peter Boogaard, Founder, Industrial Lab Automation. Wednesday 26th February 2014, 9.00am – 13.00pm, Marriott Hotel Regents Park, London, UK.
For more information on the programme and speakers please visit the website. Register by 31st October and save £300.